Literature DB >> 18433866

Salvage therapy with lenalidomide and dexamethasone in relapsed primary plasma cell leukemia.

Pellegrino Musto, Giuseppe Pietrantuono, Roberto Guariglia, Oreste Villani, Maria Carmen Martorelli, Fiorella D'Auria, Antonia Zonno, Rosa Lerose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18433866     DOI： 10.1016/j.leukres.2008.03.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  10 in total

1.  Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia.

Authors:  P Musto; V Simeon; M C Martorelli; M T Petrucci; N Cascavilla; F Di Raimondo; T Caravita; F Morabito; M Offidani; A Olivieri; G Benevolo; R Mina; R Guariglia; G D'Arena; G Mansueto; N Filardi; F Nobile; A Levi; A Falcone; M Cavalli; G Pietrantuono; O Villani; S Bringhen; P Omedè; R Lerose; L Agnelli; K Todoerti; A Neri; M Boccadoro; A Palumbo
Journal:  Leukemia       Date:  2013-08-20       Impact factor: 11.528

Review 2.  How I treat plasma cell leukemia.

Authors:  Niels W C J van de Donk; Henk M Lokhorst; Kenneth C Anderson; Paul G Richardson
Journal:  Blood       Date:  2012-07-26       Impact factor: 22.113

Review 3.  Plasma cell leukaemia and other aggressive plasma cell malignancies.

Authors:  Taimur Sher; Kena C Miller; George Deeb; Kelvin Lee; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2010-08       Impact factor: 6.998

Review 4.  Plasma cell leukemia.

Authors:  Flavio Albarracin; Rafael Fonseca
Journal:  Blood Rev       Date:  2011-02-03       Impact factor: 8.250

Review 5.  Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Authors:  C Fernández de Larrea; R A Kyle; B G M Durie; H Ludwig; S Usmani; D H Vesole; R Hajek; J F San Miguel; O Sezer; P Sonneveld; S K Kumar; A Mahindra; R Comenzo; A Palumbo; A Mazumber; K C Anderson; P G Richardson; A Z Badros; J Caers; M Cavo; X LeLeu; M A Dimopoulos; C S Chim; R Schots; A Noeul; D Fantl; U-H Mellqvist; O Landgren; A Chanan-Khan; P Moreau; R Fonseca; G Merlini; J J Lahuerta; J Bladé; R Z Orlowski; J J Shah
Journal:  Leukemia       Date:  2012-11-21       Impact factor: 11.528

Review 6.  Primary Plasma Cell Leukemia: Identity Card 2016.

Authors:  Pellegrino Musto; Vittorio Simeon; Katia Todoerti; Antonino Neri
Journal:  Curr Treat Options Oncol       Date:  2016-04

7.  Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.

Authors:  A Mahindra; M E Kalaycio; J Vela-Ojeda; D H Vesole; M-J Zhang; P Li; J R Berenson; J M Bird; A Dispenzieri; J L Gajewski; R P Gale; L Holmberg; S Kumar; R A Kyle; H M Lazarus; S Lonial; J Mikhael; G A Milone; R Munker; R Nath; S Saccaro; L Bik To; D T Vogl; B Wirk; P Hari
Journal:  Leukemia       Date:  2011-11-01       Impact factor: 11.528

8.  Identification and monitoring of Copy Number Variants (CNV) in monoclonal gammopathy.

Authors:  Fabio Sallustio; Claudia Curci; Antonio Giovanni Solimando; Patrizia Leone; Paola Pontrelli; Loreto Gesualdo; Angelo Vacca; Vito Racanelli; Anna Gallone
Journal:  Cancer Biol Ther       Date:  2021-07-21       Impact factor: 4.875

9.  Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.

Authors:  Tommasina Guglielmelli; Roberta Merlini; Emilia Giugliano; Giuseppe Saglio
Journal:  J Oncol       Date:  2009       Impact factor: 4.375

10.  Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.

Authors:  Giampaolo Talamo; Nathan G Dolloff; Kamal Sharma; Junjia Zhu; Jozef Malysz
Journal:  Rare Tumors       Date:  2012-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.